Heart failure & cardiomyopathies
METAB-HTX: Prospective, Longitudinal Cohort Study Evaluating Cardiac and Systemic Metabolism After Heart Transplantation
Study context
- Population
- Patients post-HTXplanned enrolment over a period of 5 years
- Participants
- 400 participants
- Primary endpoint
- Incidence of heart transplant events, defined as worsening of systolic or diastolic left ventricular function, coronary allograft vasculopathy (CAV), allograft rejection, worsening of kidney function, metabolic liver disease, infections, neoplasia, deterioration of glucose and lipid metabolism
No results yet. This paper sets out the design of a trial; its results are to come.
Original publication
METAB-HTX: Prospective, Longitudinal Cohort Study Evaluating Cardiac and Systemic Metabolism After Heart Transplantation. ESC Heart Fail. Published 15 May 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →